Advertisement
Screener

Humacyte, Inc. (HUMA) Material Contracts

Humacyte, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-04-24: Form 8-K; Exhibit 10.1; Description Third Amendment to Distribution Agreement, dated as of April 21, 2026, between Humacyte, Inc. and Fresenius Medical Care Holdings, Inc..
  • 2026-03-19: Form 8-K; Exhibit 10.2; Description Placement Agent Agreement, dated as of March 19, 2026, by and between Humacyte, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC..
  • 2026-03-19: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated as of March 19, 2026, by and between Humacyte, Inc. and the investors..
  • 2025-12-16: Form 8-K; Exhibit 10.1; Description Sales Agreement, dated as of December 16, 2025, by and between Humacyte, Inc. and TD Securities (USA) LLC..
FiledFormExhibitDescription
2026-04-248-K10.1Third Amendment to Distribution Agreement, dated as of April 21, 2026, between Humacyte, Inc. and Fresenius Medical Care Holdings, Inc.
2026-03-198-K10.2Placement Agent Agreement, dated as of March 19, 2026, by and between Humacyte, Inc. and Titan Partners Group LLC, a division of American Capital Partners, LLC.
2026-03-198-K10.1Form of Securities Purchase Agreement, dated as of March 19, 2026, by and between Humacyte, Inc. and the investors.
2025-12-168-K10.1Sales Agreement, dated as of December 16, 2025, by and between Humacyte, Inc. and TD Securities (USA) LLC.
2025-12-158-K10.1Loan and Security Agreement, dated as of December 15, 2025, by and among Humacyte Global, Inc., as borrower representative and a borrower, Humacyte, Inc. as a borrower, and Avenue Venture Opportunities Fund II, L.P., as lender, administrative agent and collateral agent.
2025-11-1210-Q10.3Sixth Amendment to Lease, dated September 29, 2025, between ARE–NC Region No. 5, LLC and Humacyte, Inc.
2025-11-1210-Q10.2Fifth Amendment to Lease, dated September 4, 2019, between ARE–NC Region No. 5, LLC and Humacyte, Inc.
2025-10-078-K10.2Placement Agent Agreement, dated as of October 6, 2025, by and between Humacyte, Inc. and D. Boral Capital LLC.
2025-10-078-K10.1Securities Purchase Agreement, dated as of October 6, 2025, by and between Humacyte, Inc. and the investors.
2025-09-188-K10.1Amendment No. 2 to the Revenue Interest Purchase Agreement, dated as of September 17, 2025, by and among Humacyte Global, Inc., Humacyte, Inc. and TPC Investments III LP and TPC Investment Solutions LP and Hook SA LLC.
2024-11-148-K10.1Securities Purchase Agreement, dated as of November 13, 2024, by and between Humacyte, Inc. and the investor
2024-10-078-K10.2Placement Agent Agreement, dated as of October 4, 2024, by and between Humacyte, Inc. and EF Hutton LLC.
2024-10-078-K10.1Securities Purchase Agreement, dated as of October 4, 2024, by and between Humacyte, Inc. and the investor.
2024-09-258-K10.2Registration Rights Agreement, dated as of September 24, 2024, by and between Humacyte, Inc. and Lincoln Park Capital Fund, LLC.
2024-09-258-K10.1Purchase Agreement, dated as of September 24, 2024, by and between Humacyte, Inc. and Lincoln Park Capital Fund, LLC.
2024-08-1310-Q10.1Waiver and Amendment, dated as of May 8, 2024, by and among Humacyte Global, Inc., Humacyte, Inc. and Hook SA LLC.
2024-03-2810-K10.12Waiver, dated as of February 18, 2024, by and among Humacyte Global, Inc., Humacyte, Inc. and Hook SA LLC.
2023-08-1410-Q10.1Revenue Interest Purchase Agreement, dated as of May 12, 2023, by and among Humacyte Global, Inc., Humacyte, Inc. and Hook SA LLC.
2023-03-2410-K10.12Executive Employment Agreement, effective as of April 4, 2022 between Shamik Parikh, MD and Humacyte, Inc.
2023-03-2410-K10.11Executive Employment Agreement, dated May 18, 2021, between Dale Sander and Humacyte, Inc.
2022-03-2910-K10.11.2Executive Separation and Release Agreement, dated December 23, 2021, between Jeffrey Lawson, M.D. and Humacyte, Inc.
2022-03-2910-K10.7.6Sixth Amendment to Exclusive Patent License Agreement, dated January 10, 2022, between Duke University and Humacyte Global, Inc.
2021-08-308-K10.8Humacyte, Inc. Annual Bonus Plan.
2021-08-308-K10.5Humacyte, Inc. 2021 Employee Stock Purchase Plan.
2021-08-308-K10.4.1Form of Stock Option Agreement under Humacyte, Inc. 2021 Long-Term Incentive Plan.
2021-08-308-K10.4Humacyte, Inc. 2021 Long-Term Incentive Plan.
2021-02-178-K10.1FORM OF SUBSCRIPTION AGREEMENT
2020-09-228-K10.7NORTHLAND UNIT SUBSCRIPTION AGREEMENT
2020-09-228-K10.6OPCO UNIT SUBSCRIPTION AGREEMENT
2020-09-228-K10.5SPONSOR UNIT SUBSCRIPTION AGREEMENT
2020-09-228-K10.4ADMINISTRATIVE SUPPORT AGREEMENT
2020-09-228-K10.3FORM OF REGISTRATION RIGHTS AGREEMENT
2020-09-228-K10.2INVESTMENT MANAGEMENT TRUST AGREEMENT
2020-09-228-K10.1LETTER AGREEMENT

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48
enGene Therapeutics Inc. (ENGN)$0.129B-0.92
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63